share_log

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Nanis Nikolaos P.

Teladoc Health | 4: Statement of changes in beneficial ownership of securities

Teladoc Health | 4：持股变动声明
SEC announcement ·  04/03 16:09
Moomoo AI 已提取核心信息
Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, Inc. (TDOC), completed a sale of 461 shares of common stock on April 2, 2024. The transaction was executed at a price of $14.314 per share, resulting in a total sale value of $6,598.75. Prior to this sale, Nanis exercised options to acquire 1,232 shares on April 1, 2024. Following these transactions, Nanis holds a total of 70,621 shares in the company. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security, both involving direct ownership.
Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, Inc. (TDOC), completed a sale of 461 shares of common stock on April 2, 2024. The transaction was executed at a price of $14.314 per share, resulting in a total sale value of $6,598.75. Prior to this sale, Nanis exercised options to acquire 1,232 shares on April 1, 2024. Following these transactions, Nanis holds a total of 70,621 shares in the company. The sale was conducted as an open market or private sale, while the acquisition was due to the exercise or conversion of derivative security, both involving direct ownership.
Teladoc Health, Inc.（TDOC）首席技术官尼古拉斯·纳尼斯于2024年4月2日完成了461股普通股的出售。该交易以每股14.314美元的价格执行，总销售价值为6,598.75美元。在此次出售之前，纳尼斯于2024年4月1日行使了期权收购了1,232股股票。在这些交易之后，纳尼斯共持有该公司70,621股股份。此次出售以公开市场或私人销售的形式进行，而收购是由于行使或转换衍生证券，两者都涉及直接所有权。
Teladoc Health, Inc.（TDOC）首席技术官尼古拉斯·纳尼斯于2024年4月2日完成了461股普通股的出售。该交易以每股14.314美元的价格执行，总销售价值为6,598.75美元。在此次出售之前，纳尼斯于2024年4月1日行使了期权收购了1,232股股票。在这些交易之后，纳尼斯共持有该公司70,621股股份。此次出售以公开市场或私人销售的形式进行，而收购是由于行使或转换衍生证券，两者都涉及直接所有权。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息